Reumatologia
OncologiaMedica.net
Neurologia
OncoGinecologia.net

UrologyNews.net

Urology Xagena

Preclinical urothelial carcinoma models suggest activity of Dasatinib ( Sprycel ), an oral Src-family kinase ( SFK ) inhibitor. Researchers have determined the feasibility and biologic activity of n ...


Researchers have evaluated the association of ABO blood type with clinicopathologic outcomes and mortality among patients with urothelial carcinoma of the bladder treated with radical cystectomy. 2 ...


Late recurrence of renal cell carcinoma is not a rare event. A retrospective study has investigated the clinicopathological features and the outcome of patients treated with Sorafenib ( Nexavar ), Sun ...


Researchers aimed to identify clinical predictors of long-term response to Abiraterone [ Zytiga ] ( defined as more than 12 months drug exposure ) in a retrospective cohort of metastatic castration-re ...


Pancreatic metastases from renal cell carcinoma are uncommon and their prognostic significance is not well defined. Br> An analysis has evaluated the outcome of patients with pancreatic metastas ...


Studies investigating the association of food and nutrient consumption with the risk of urothelial cell carcinoma ( UCC ) have produced mixed results. Researchers used three common dietary scores, t ...


Little is known about the outcomes and prognostic factors of adjuvant chemotherapy for locally advanced penile squamous cell carcinoma after regional lymphadenectomy ( LAD ). Researchers have retro ...


The efficacy and safety of a combination of chemotherapeutic agent compared with single-agent chemotherapy in the second-line setting of advanced urothelial carcinoma ( UC ) are unclear. Researchers ...


The FDA ( U.S. Food and Drug Administration ) has granted accelerated approval to Tecentriq ( Atezolizumab ) for the treatment of people with locally advanced or metastatic urothelial carcinoma ( mUC ...


Ureteral stent-related pain is a well-known side effect of stent placement. To date, there is a paucity of resources that address this topic. Stent pain pathophysiology is multifactorial and likely ...


The results from the STRIVE trial of Enzalutamide ( Xtandi ) compared to Bicalutamide ( Casodex ) in men with castration-resistant prostate cancer ( CRPC ) are published in the Journal of Clinical Onc ...


The results from the phase 2 TERRAIN trial of Enzalutamide ( Xtandi ) compared to Bicalutamide ( Casodex ) in metastatic castration-resistant prostate cancer ( CRPC ) are published in the Lancet Oncol ...


Recent guidelines recommend against routine screening for prostate cancer, partly because of the risks associated with overtreatment of clinically indolent tumours. A study aimed to determine the ...


A study has analyzed the proportion of men taking Tadalafil ( Cialis ) 5 mg once-daily who reach a combined improvement ( henceforth known as a combined responder ) in symptoms of both erectile dysfun ...


The aim of a study was to evaluate the safety profile of Abiraterone acetate ( Zytiga ) in metastatic castration-resistant prostate cancer ( mCRPC ) men with cardiovascular comorbidity, as little conc ...